Skip to search formSkip to main contentSkip to account menu

Drug Repositioning

Known as: Drug Repurposing, Repositioning, Drug, Repurposing, Drug 
The deliberate and methodical practice of finding new applications for existing drugs.
National Institutes of Health

Related topics

Related topics

3 relations
Drug RescueOff-Label Treatmentstandards characteristics

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
Identification of promising drug candidates against NSP16 of SARS-CoV-2 through computational drug repurposing study
Abstract The recent outbreak of the SARS-CoV-2 virus leading to the disease COVID 19, a global pandemic has resulted in an… 
2019
2019
Inhibitory mechanism of an anticancer drug, Bexarotene against Amyloid β peptide aggregation: Repurposing via neuroinformatics approach.
Aggregation of Amyloid β (Aβ) peptide is a crucial feature of Alzheimer disease (AD) pathogenesis. In fact, Aβ peptides are… 
Review
2019
Review
2019
Basics on the use of acid-sensing ion channels’ inhibitors as therapeutics
Since the discovery of acid-sensing ion channels in 1997, their importance in the health of neurons and other non-neuronal cells… 
2018
2018
Connecting genetics and gene expression data for target prioritisation and drug repositioning
Developing new drugs continues to be a highly inefficient and costly business. By repurposing an existing compound for a… 
Review
2016
Review
2016
Revisiting Repurposing.
Drug repurposing can be a cost-effective strategy to identify new small molecule-based therapies. Thus, drug repurposing… 
Review
2016
Review
2016
Recommendation Techniques for Drug-Target Interaction Prediction and Drug Repositioning.
The usage of computational methods in drug discovery is a common practice. More recently, by exploiting the wealth of biological… 
2016
2016
Mining integrated semantic networks for drug repositioning opportunities
Current research and development approaches to drug discovery have become less fruitful and more costly. One alternative paradigm… 
Review
2011
Review
2011
New sources of drugs for hematologic malignancies.
Advancing novel therapeutic agents for the treatment of malignancy into the marketplace is an increasingly costly and lengthy… 
2011
2011
Nonprofit disease groups earmark grants for drug repositioning
Prompted by the low success rates and high costs of drug development, pharmaceutical companies have increasingly turned to drug… 
2009
2009
Drug repositioning summit: finding new routes to success.
The Third Annual Drug Repositioning Summit 2008 was held at the Hyatt Harborside Hotel in Boston, Massachusetts, October 6-7, and… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)